Is Microbot Medical Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: MBOT) stock is to Buy MBOT stock.
Out of 1 analyst, 0 (0%) are recommending MBOT as a Strong Buy, 1 (100%) are recommending MBOT as a Buy, 0 (0%) are recommending MBOT as a Hold, 0 (0%) are recommending MBOT as a Sell, and 0 (0%) are recommending MBOT as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year MBOT price target, the average MBOT price target is $7.00, with the highest MBOT stock price forecast at $7.00 and the lowest MBOT stock price forecast at $7.00.
The Wall Street analyst predicted that Microbot Medical's share price could reach $7.00 by Apr 16, 2025. The average Microbot Medical stock price prediction forecasts a potential upside of 685.63% from the current MBOT share price of $0.89.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.